The utility of genetically modified mouse assays for identifying human carcinogens: a basic understanding and path forward. The Alternatives to Carcinogenicity Testing Committee ILSI HESI.

نویسندگان

  • James MacDonald
  • John E French
  • Ronald J Gerson
  • Jay Goodman
  • Tohru Inoue
  • Abigail Jacobs
  • Peter Kasper
  • Douglas Keller
  • Amy Lavin
  • Gerald Long
  • Bruce McCullough
  • Frank D Sistare
  • Richard Storer
  • Jan Willem van der Laan
چکیده

The Alternatives to Carcinogenicity Testing Committee of the International Life Sciences Institute (ILSI) Health and Environmental Sciences Institute (HESI) conducted a large-scale, multinational collaborative research program to evaluate several genetically modified mouse assays for assessing the human carcinogenic potential of compounds. The data from this testing program have made an important contribution to the general understanding of how these models can be best applied in hazard identification; however, questions still exist regarding methodology and data interpretation. To address these issues, ILSI HESI hosted a February 2003 workshop on the Utility of Transgenic Assays for Risk Assessment. The purpose of this workshop was to reach an understanding of how data from genetically modified mouse models are viewed by different regulatory bodies in the pharmaceutical sector and, based on this understanding, to identify areas in which more experimental work may be needed to increase the utility of data derived from these assays. In the course of discussions, various data gaps related to model selection and protocol issues were identified. Based on the outcome of the workshop, various studies are proposed to provide data to improve the utility of currently available assays for cancer hazard identification and risk assessment purposes.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

European Medicines Agency Evaluation of Medicines for Human Use

The Note for Guidance ICH S1B Testing for Carcinogenicity of Pharmaceuticals (CPMP/ICH/299/95) offers the option to use short or medium-term in vivo rodent test systems, such as transgenic and knockout animal models, in place of a second 2-year rodent bioassay. Ideally, such studies should supplement the long-term carcinogenicity study and provide additional information that is not readily avai...

متن کامل

RIVM report 340700001/2004 Transgenic mice as alternatives in carcinogenicity testing: current status

The correct prediction of human risk after exposure to chemical and physical compounds has long been a major challenge. For this, the lifetime bioassay using rats and mice is routinely used. However, over the years this assay has clearly come to reveal several drawbacks; for example, large numbers of animals are used, and the assays are slow, insensitive and expensive. On top of this, there is ...

متن کامل

Assessment of human cancer risk: challenges for alternative approaches.

The ILSI/HESI Workshop on Alternatives to Carcinogenicity Testing aims to develop and apply new methods for assessment of potential carcinogenic risk to humans from various chemicals. The Workshop represents a major cooperative scientific effort. The long-term goals should be to greatly enhance the efficiency and reliability of such testing and to supplant, not just supplement, lifetime rodent ...

متن کامل

Focus On: Genetically Altered Mouse Cancer Models Testing Compounds in Genetically Altered Mice

ABSTRAC~ National Institute of Environmental Health Sciences researchers are exploring the utility of genetically altered mice to study mechanisms of carcinogenesis. Two of these mouse models, the Tg.AC (carrier of an activated mouse H-ms oncogene) and the p53+ (heterozygous for the wild-type tumor suppressor gene Trp53), have genetic alterations that appear to hasten their expression of chemic...

متن کامل

Opportunities to integrate new approaches in genetic toxicology: an ILSI-HESI workshop report.

Genetic toxicity tests currently used to identify and characterize potential human mutagens and carcinogens rely on measurements of primary DNA damage, gene mutation, and chromosome damage in vitro and in rodents. The International Life Sciences Institute Health and Environmental Sciences Institute (ILSI-HESI) Committee on the Relevance and Follow-up of Positive Results in In Vitro Genetic Toxi...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Toxicological sciences : an official journal of the Society of Toxicology

دوره 77 2  شماره 

صفحات  -

تاریخ انتشار 2004